Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utility of High-Concentration Contrast Material for Dual-Energy CT Angiography
jRCTs041230098Completed
- Sponsor
- Bayer
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of iopromide in aortopathy (2 arms), sponsored by Bayer. Primary endpoint: Arterial visualization score for iliolumbar artery on 3D volume-rendered images. Started Nov 2023; status: completed.
02
Drugs
iopromide
03
Conditions
aortopathy
Beyond the preview
Go deeper on jRCTs041230098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230098.